Based on the fact that fenfluramines are well-established substrates for 5-HT transporter (SERT) proteins, we proposed a “gateway hypothesis” to explain fenfluramine-induced PAH [2]. Here, SLC6A4 is linked to pulmonary arterial hypertension.